2m 2m 2m 2m 2m 2m 2m
HARVARD BIO (HBIO)
NASDAQ
$9.70+$0.02 (+0.21%)
Price as of Nov 12, 2026 8:59 AM EST- $44.1MMarket Cap
- 55.60%1-Year Change
- Medical Instruments & SuppliesIndustry
HARVARD BIO (HBIO)
$9.70+$0.02 (+0.21%)
HBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.68 | ||
Change | +$0.42 (+4.54%) | ||
Open | $9.46 | ||
High | $10.20 | ||
Low | $9.30 | ||
Previous Close | $9.26 | ||
Volume | 105,422 | ||
30-Day Average Volume | 27,200 | ||
1-Week Change | 12.43% | ||
1-Month Change | 17.48% | ||
1-Year Change | 55.60% | ||
3-Year Change | -75.80% | ||
5-Year Change | -87.49% | ||
Fundamentals | |||
Shares Outstanding | 4.6M | ||
Total Assets | $75.3M | ||
Market Cap | $44.1M | ||
Enterprise Value | $76.4M | ||
Period: QTR TTM FY | |||
Revenue | $22.2M | ||
Net Income | -$2.6M | ||
Free Cash Flow | -$1.2M | ||
EBIT | -$912,000.00 | ||
EBITDA | -$412,000.00 | ||
Net Working Capital | $19.9M | ||
EPS | -$0.58 | ||
Enterprise Value/EBITDA | -185 | ||
Enterprise Value/Revenue | 3 | ||
P/B | 9 | ||
P/E | -17 | ||
PEG | -2 | ||
Price/Free Cash Flow | -38 | ||
Price/Operating Cash Flow | -178 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 03/16/2026 | ||
Earnings & Revenue